Chemotherapy as prophylaxis and treatment of meningosis in children less than 3 years of age with medulloblastoma

Journal of Neuro-Oncology

Volumn 38, Issue 2-3, 1998, Pages 187-192

  Schmandt, Susanne ^a   Kühl, Joachim ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Chemotherapy; Infant; Medulloblastoma; Meningosis

Indexed keywords

ALKYLATING AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; MAFOSFAMIDE; METHOTREXATE; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILD; CHILDHOOD CANCER; CONFERENCE PAPER; GROWTH HORMONE DEFICIENCY; HUMAN; INTRATHECAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; MENTAL DEFICIENCY; PRESCHOOL CHILD; QUALITY OF LIFE; SCHOOL CHILD; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0031780793     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005924017460     Document Type: Conference Paper

References (24)

1. Duffner PK: Brain tumors in infants and very young children. In: Cohen ME, Duffner PK (eds) Brain Tumors in Children: Principles of Diagnosis and Treatment. Raven Press, Ltd., New York 400-421, 1994
2. Baram TZ, van Eys J, Dowell RE, Cangir A, Pack B, Bruner JM: Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy. Cancer 60: 173-177, 1987
3. Tomita T, McLone DG: Brain tumors during the first twenty-four months of life. Neurosurgery 17: 913-919, 1985
4. Cohen BH, Packer RJ, Siegel KR, Rorke LB, D'Angio G, Sutton LN, Bruce DA, Schut L: Brain tumors in children under 2 years: Treatment, survival and long-term prognosis. Pediatr Neurosurg 19: 171-179, 1993
5. Kretschmar CS, Tarbell NJ, Kupsky W, Lavally BL, Loeffler JS, Wolfe L, Strand R, Scott M, Sallan SE: Pre-irradiation chemotherapy for infants and children with medulloblastoma: a preliminary report. J Neurosurg 71: 820-825, 1989
6. Packer RJ, Sutton LN, Goldwein JW, Perilongo G, Bunin G, Ryan J, Cohen BH, D'Angio G, Kramer ED, Zimmerman RA, Rorke LB, Evans AE, Schut L: Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74: 433-440, 1991
7. Goldwein JW, Radcliffe J, Johnson J, Moshang T, Packer RJ, Sutton LN, Rorke LB, D'Angio GJ: Updated results of a pilot study of low-dose craniospinal irradiation plus chemotherapy for children under five with cerebellar primitive neuroectodermal tumors (medulloblastoma). Int J Radiat Oncol Biol Phys 34: 899-904, 1996
8. Baram TZ, van Eys J, Dowell RE, Cangir A, Pack B, Bruner JM: Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy. Cancer 60: 173-177, 1987
9. Packer RJ: Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa. Ann Neurol 28: 823-828, 1990
10. van Eys J, Cangir A, Coody D, Smith B: MOPP regimen as primary chemotherapy for brain tumors in infants. Neuro-Oncol 3: 237-243, 1985
11. Horowitz ME, Mulhern RK, Kun LE, Kovnar E, Sanford RA, Simmons J, Hayes FA, Jenkins III JJ: Brain tumors in the very young child. Postoperative chemotherapy in combined-modality treatment. Cancer 61: 428-434, 1988
12. Geyer JR, Zeltzer PM, Boyett JM, Rorke LB, Stanley P, Albright AL, Wisoff JH, Milstein JM, Allen JC, Finley JL, Ayers GD, Shurin SB, Stevens KR, Bleyer WA: Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: A report from the Children's Cancer Group. J Clin Oncol 12: 1607-1615, 1994
13. Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME, Sanford RA, Mulhern RK, James HE, Freeman CR, Seidel FG, Kun LE: Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328: 1725-1731, 1993
14. Kühl J, Gnekow A, Havers W, Lampert F, Spaar HJ, Mass E, Graf N, Bode U: Primary chemotherapy after surgery and delayed irradiation in children under three years of age with medulloblastoma. Med Pediatr Oncol 20: 387 (A 68), 1992
15. White L, Johnston H, Jones R, Mameghan H, Nayanar V, McWhirter W, Kellie S, Waters K, Toogood I: Postoperative chemotherapy without radiation in young children with malignant non-astrocytic brain tumors. Cancer Chemother Pharmacol 32: 403-406, 1993
16. Glauser TA, Packer RJ: Cognitive deficits in long-term survivors of childhood brain tumors. Child's Nerv Syst 7: 2-12, 1991
17. Kühl J, Berthold F, Bode U, Bucsky P, Graf N, Gnekow A, Maass E, Bamberg M, Kaatsch P, Kleihues P, Rating D, Riehm H, Sörensen N: Preradiation chemotherapy of children with poor-prognosis medulloblastoma: Response rate and toxicity of the ifosfamid-containing multidrug regimen HIT '88/'89. Am J Pediatr Hematol Oncol 15: S67-71, 1993
18. Kühl J, Beck J, Bode U et al.: Delayed radiation therapy after postoperative chemotherapy in children less than three years of age with medulloblastoma. Med Pediatr Oncol 25: 250 (A O-67), 1995
19. Hartmann O, Valteau-Couanet D, Dupuis S, Doz F, Gentet JC, Méchinaud F, Bouffet E, Benhamou E, Kalifa C: High-dose chemotherapy followed by autologous bone marrow transplantation in place of craniospinal irradiation in young children treated for medulloblastoma? Med Pediatr Oncol 25 (4): 251 (A O-70), 1995
20. Dunkel I, Garvin J, Allen J, Boyett J, Heller G, Yates A, Rosenblum M, Bayer L, Geyer J, Lindsley K, Goldman S, Sender L, Cowan M, Jennings M, Bostrom B, Sanders J, Finlay JL: High-dose chemotherapy with autologous stem cell rescue in patients with recurrent medulloblastoma. Med Pediatr Oncol 25 (4): 298 (A P-79), 1995
21. Finlay JL, Grovas A, Garvin J, Dunkel I, Bayer L, Puccetti D, Halpern S, Drachtman R, Goldman S, Tugal O, Jayabose S, Weinblatt M, SadhevI, Allen JC: The 'head start'regimen for children less than 6 years of age newly-diagnosed with malignant brain tumors. Med Pediatr Oncol 25 (4): 250 (A O-69), 1995
22. Slave I, Schuller E, Seidl R, Czech T, Dieckmann K: Intraventricular mafosfamide in pediatric brain tumor patients with meningeal dissemination. J Neuro-Oncol 30 (2): 137 (AP-172), 1996
23. 131I monoclonal antibody therapy for leptomeningeal primitive tumors. Med Pediatr Oncol 25 (4): 241 (A 0-33), 1995
24. Chen J, Willingham T, Nisen PD : Gene therapy for CNS malignancies: Effects of the MYC oncogene antagonist MAD, and the cyclin-dependent kinase inhibitors p21 and p27 on the malignant phenotype of human brain tumor cells. Med Pediatr Oncol 25 (4): 243 (A O-41), 1995